Learnings from the latest PCSK9i results and and profiles of patients who may benefit the most: efficacy and safety of alirocumab in ODYSSEY OUTCOMES patients with diabetes
27 August 2018 (18:35 - 18:45)
Organised by:
Slides
About the speaker
Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
6 More presentations in this session
Professor A. Zeiher (Frankfurt, DE)
Professor P. Steg (Paris, FR)
Professor A. Zeiher (Frankfurt, DE)
Access the full session
The Event
ESC Congress 2018
27 August 2018
18:35 CET
